Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -33.69% | 23.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -33.69% | 23.27% | |||
| Cost of Revenue | -33.96% | 23.75% | |||
| Gross Profit | -33.46% | 22.86% | |||
| SG&A Expenses | -12.99% | 15.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.36% | 8.16% | |||
| Operating Income | -46.19% | 15.50% | |||
| Income Before Tax | 15.29% | -64.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.29% | -64.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.29% | -64.72% | |||
| EBIT | -46.19% | 15.50% | |||
| EBITDA | -57.31% | 17.92% | |||
| EPS Basic | 17.76% | -35.78% | |||
| Normalized Basic EPS | 22.98% | -35.74% | |||
| EPS Diluted | 17.76% | -35.78% | |||
| Normalized Diluted EPS | 22.98% | -35.74% | |||
| Average Basic Shares Outstanding | 3.06% | 21.32% | |||
| Average Diluted Shares Outstanding | 3.06% | 21.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||